Literature DB >> 17428917

Smallpox subunit vaccine produced in Planta confers protection in mice.

Maxim Golovkin1, Sergei Spitsin, Vyacheslav Andrianov, Yuriy Smirnov, Yuhong Xiao, Natalia Pogrebnyak, Karen Markley, Robert Brodzik, Yuri Gleba, Stuart N Isaacs, Hilary Koprowski.   

Abstract

We report here the in planta production of the recombinant vaccinia virus B5 antigenic domain (pB5), an attractive component of a subunit vaccine against smallpox. The antigenic domain was expressed by using efficient transient and constitutive plant expression systems and tested by various immunization routes in two animal models. Whereas oral administration in mice or the minipig with collard-derived insoluble pB5 did not generate an anti-B5 immune response, intranasal administration of soluble pB5 led to a rise of B5-specific immunoglobulins, and parenteral immunization led to a strong anti-B5 immune response in both mice and the minipig. Mice immunized i.m. with pB5 generated an antibody response that reduced virus spread in vitro and conferred protection from challenge with a lethal dose of vaccinia virus. These results indicate the feasibility of producing safe and inexpensive subunit vaccines by using plant production systems.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17428917      PMCID: PMC1871876          DOI: 10.1073/pnas.0701451104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Antibody neutralization of the extracellular enveloped form of vaccinia virus.

Authors:  M Law; G L Smith
Journal:  Virology       Date:  2001-02-01       Impact factor: 3.616

Review 2.  Design and production of recombinant subunit vaccines.

Authors:  M Hansson; P A Nygren; S Ståhl
Journal:  Biotechnol Appl Biochem       Date:  2000-10       Impact factor: 2.431

3.  DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge.

Authors:  J W Hooper; D M Custer; C S Schmaljohn; A L Schmaljohn
Journal:  Virology       Date:  2000-01-20       Impact factor: 3.616

4.  Vaccine manufacturing: challenges and solutions.

Authors:  Jeffrey B Ulmer; Ulrich Valley; Rino Rappuoli
Journal:  Nat Biotechnol       Date:  2006-11       Impact factor: 54.908

5.  The promoter-terminator of chrysanthemum rbcS1 directs very high expression levels in plants.

Authors:  N S Outchkourov; J Peters; J de Jong; W Rademakers; M A Jongsma
Journal:  Planta       Date:  2003-01-10       Impact factor: 4.116

6.  Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates.

Authors:  J W Hooper; D M Custer; E Thompson
Journal:  Virology       Date:  2003-02-01       Impact factor: 3.616

7.  Constitutive expression of the beta-ketothiolase gene in transgenic plants. A major obstacle for obtaining polyhydroxybutyrate-producing plants.

Authors:  Karen Bohmert; Ilse Balbo; Alexander Steinbüchel; Gilbert Tischendorf; Lothar Willmitzer
Journal:  Plant Physiol       Date:  2002-04       Impact factor: 8.340

8.  A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost.

Authors:  Yuhong Xiao; Lydia Aldaz-Carroll; Alexandra M Ortiz; J Charles Whitbeck; Edward Alexander; Huan Lou; Heather L Davis; Thomas J Braciale; Roselyn J Eisenberg; Gary H Cohen; Stuart N Isaacs
Journal:  Vaccine       Date:  2006-10-17       Impact factor: 3.641

Review 9.  Smallpox vaccination: a review, part I. Background, vaccination technique, normal vaccination and revaccination, and expected normal reactions.

Authors:  Vincent A Fulginiti; Arthur Papier; J Michael Lane; John M Neff; D A Henderson
Journal:  Clin Infect Dis       Date:  2003-07-10       Impact factor: 9.079

10.  Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle.

Authors:  Pamela A Kozlowski; Selvi B Williams; Rebecca M Lynch; Timothy P Flanigan; Rosalyn R Patterson; Susan Cu-Uvin; Marian R Neutra
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

View more
  18 in total

Review 1.  Principles of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agents.

Authors:  S Ramasamy; C Q Liu; H Tran; A Gubala; P Gauci; J McAllister; T Vo
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

Review 2.  Emerging antibody products and Nicotiana manufacturing.

Authors:  Kevin J Whaley; Andrew Hiatt; Larry Zeitlin
Journal:  Hum Vaccin       Date:  2011-03-01

Review 3.  Expression of recombinant vaccines and antibodies in plants.

Authors:  Kisung Ko
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2014-06

4.  Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin.

Authors:  Marc Pearton; Sang-Moo Kang; Jae-Min Song; Yeu-Chun Kim; Fu-Shi Quan; Alexander Anstey; Matthew Ivory; Mark R Prausnitz; Richard W Compans; James C Birchall
Journal:  Vaccine       Date:  2010-06-08       Impact factor: 3.641

5.  The identification of HLA class II-restricted T cell epitopes to vaccinia virus membrane proteins.

Authors:  Richard B Kennedy; Gregory A Poland
Journal:  Virology       Date:  2010-10-18       Impact factor: 3.616

6.  Comparative evaluation of the immune responses and protection engendered by LC16m8 and Dryvax smallpox vaccines in a mouse model.

Authors:  Clement A Meseda; Anne E Mayer; Arunima Kumar; Alonzo D Garcia; Joseph Campbell; Paul Listrani; Jody Manischewitz; Lisa R King; Hana Golding; Michael Merchlinsky; Jerry P Weir
Journal:  Clin Vaccine Immunol       Date:  2009-07-15

7.  Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates.

Authors:  Jay W Hooper; Anthony M Ferro; Joseph W Golden; Peter Silvera; Jeanne Dudek; Kim Alterson; Max Custer; Bryan Rivers; John Morris; Gary Owens; Jonathan F Smith; Kurt I Kamrud
Journal:  Vaccine       Date:  2009-10-13       Impact factor: 3.641

Review 8.  Smallpox vaccines for biodefense.

Authors:  Richard B Kennedy; Inna Ovsyannikova; Gregory A Poland
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

9.  Antibody against extracellular vaccinia virus (EV) protects mice through complement and Fc receptors.

Authors:  Matthew E Cohen; Yuhong Xiao; Roselyn J Eisenberg; Gary H Cohen; Stuart N Isaacs
Journal:  PLoS One       Date:  2011-06-08       Impact factor: 3.240

Review 10.  Plant-made vaccine antigens and biopharmaceuticals.

Authors:  Henry Daniell; Nameirakpam D Singh; Hugh Mason; Stephen J Streatfield
Journal:  Trends Plant Sci       Date:  2009-10-14       Impact factor: 18.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.